AMP 2022 video: Immunexpress CEO describes rapid molecular test for sepsis

Leo O'Connor
Nov 15, 2022
Latest in Point-of-Care Testing
Nurse Doctor Patient Black Woman Social
Quest Diagnostics offers suite of services for transplant patients and living donors
March 23, 2023
Brain Puzzle Dementia Social
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
March 22, 2023
Computer Display Monitor Lab Mri V1 Social
Patients prefer immediate test results, even when the news is bad
March 21, 2023
Business Financial Stock Drop Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
March 21, 2023
Related Stories
Bacteria Blood Sepsis Social
Sepsis
Asep Medical inks joint venture term sheet with Sansure Biotech, preps sepsis test for launch in China
Sepsis Bacteria Social
Sepsis
DeepUll obtains 20-million-euro loan to develop point-of-care sepsis test
Thermo Video
Sequencing
AMP 2022 video: Thermo Fisher Scientific discusses NGS system adoption
Img Updated
Gene expression
At AMP 2022, Immunexpress launches rapid test for sepsis requiring two minutes hands-on time
More in Point-of-Care Testing
Quest Diagnostics offers suite of services for transplant patients and living donors
The offerings of the Quest Advanced Specialized Transplant Services suite include access to Quest’s national network of service centers and mobile phlebotomists for both recipients and living donors in the 48 contiguous U.S. states.
March 23, 2023
Nurse Doctor Patient Black Woman Social
CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases
The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.
March 22, 2023
Brain Puzzle Dementia Social
Patients prefer immediate test results, even when the news is bad
In a recent survey, patients overwhelmingly preferred receiving their test results immediately, even if their provider had not yet reviewed them.
March 21, 2023
Computer Display Monitor Lab Mri V1 Social
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.
March 21, 2023
Business Financial Stock Drop Social
Cue Health receives FDA emergency use authorization for molecular mpox test
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Monkeypox Virus Social
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.
March 20, 2023
Hepatitis C Virus Social
Most Popular
Quest launches long-COVID testing panels for consumers
Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing
RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
Patients prefer immediate test results, even when the news is bad
Quest Diagnostics offers suite of services for transplant patients and living donors
More in Point-of-Care Testing
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
The company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.
March 16, 2023
Business Financial Results Social
Amplified Sciences developing dye-based tests for early detection of pancreatic cancer
Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.
March 15, 2023
Cancer Pancreatic Social
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Chembio “faces ongoing operational and financial challenges” if it remains an independent company, its CEO wrote in a letter to stockholders.
March 15, 2023
Business Risk Concept Social
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Glow-in-the-dark proteins, developed from the luciferase found in bioluminescent creatures, may make viral disease diagnosis quicker and easier, according to the researchers.
March 15, 2023
Crispr Cas9 Gene Editing Social
Cue Health launches at-home diagnostic tests, expands test-to-treat service
March 13, 2023
Selmo Product 065
DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions
DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.
March 13, 2023
Diabetes Woman Lancet Social
Page 1 of 36
Next Page